Summit Trail Advisors’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,831	Closed	-$76K	–	278
2018 Q2	$76K	Buy	+3,831	New	+$76K	0.03%	252
2018 Q1	–	Sell	-2,375	Closed	-$59K	–	429
2017 Q4	$59K	Buy	+2,375	New	+$59K	0.01%	773